CHEST® Resource Center
- Figure 34
ADVENT-HF: Trial Design 3
FIG. 34: This Figure outlines the primary endpoint (see also Figure 23).[12] An important aspect of ADVENT-HF is that the patients are more closely monitored than those in SERVE-HF, with follow-up every 6 months rather than every year, and the DSMB examines outcome data every 6 months. There have been 4 DSMB reviews to date and no concerns about patient safety have been identified.
Bradley D. Chest 2016;00.
References
[12]
Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure (ADVENT-HF). ClinicalTrials.gov Identifier: NCT01128816. https://clinicaltrials.gov/show/NCT01128816
